# Dysport® Adult Upper Limb Spasticity

> **NCT01313299** · PHASE3 · COMPLETED · sponsor: **Ipsen** · enrollment: 243 (actual)

## Conditions studied

- Nervous System Disorders

## Interventions

- **BIOLOGICAL:** Botulinum toxin type A
- **BIOLOGICAL:** Botulinum toxin type A
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01313299
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 243 (ACTUAL)
- **Last updated:** 2022-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01313299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01313299, "Dysport® Adult Upper Limb Spasticity". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01313299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*